Fennec Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Fennec Pharmaceuticals has a total shareholder equity of $3.0M and total debt of $31.3M, which brings its debt-to-equity ratio to 1040.1%. Its total assets and total liabilities are $69.2M and $66.2M respectively. Fennec Pharmaceuticals's EBIT is $6.2M making its interest coverage ratio 1.9. It has cash and short-term investments of $51.2M.
Key information
1,040.1%
Debt to equity ratio
US$31.35m
Debt
Interest coverage ratio | 1.9x |
Cash | US$51.18m |
Equity | US$3.01m |
Total liabilities | US$66.18m |
Total assets | US$69.19m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: RV41's short term assets ($68.2M) exceed its short term liabilities ($9.8M).
Long Term Liabilities: RV41's short term assets ($68.2M) exceed its long term liabilities ($56.3M).
Debt to Equity History and Analysis
Debt Level: RV41 has more cash than its total debt.
Reducing Debt: RV41's debt to equity ratio has increased from 0% to 1040.1% over the past 5 years.
Debt Coverage: RV41's debt is well covered by operating cash flow (87.7%).
Interest Coverage: RV41's interest payments on its debt are not well covered by EBIT (1.9x coverage).